G01N 33 - Investigating or analysing materials by specific methods not covered by groups

Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632)
12/2011
12/08/2011	US20110301046 Methods of Determining Efficacy of Glucocorticoid Treatment of Eosinophilic Esophagitis
12/08/2011	US20110301003 Industrial Roll With Multiple Sensor Arrays
12/08/2011	US20110300642 Methods for differentiating and monitoring parathyroid and bone status related diseases
12/08/2011	US20110300641 Protein isoforms for diagnosis
12/08/2011	US20110300637 Polyaniline Nanofiber Hydrogen Sensors
12/08/2011	US20110300634 Method for Determining Chromium Content in a Tungsten Matrix with Added Chromium or Simultaneously Added Chromium and Vanadium
12/08/2011	US20110300622 Apparatus and Method for Transporting Sample Well Trays
12/08/2011	US20110300605 Nanoscaling ordering of hybrid materials using genetically engineered mesoscale virus
12/08/2011	US20110300564 Diagnosis of pre-eclampsia
12/08/2011	US20110300563 Methods of preparing and operating portable, point-of-care, user-initiated fluidic assay systems
12/08/2011	US20110300562 Gdf15 as a differential marker for spondyloarthropathy
12/08/2011	US20110300561 Method for Identifying Inhibitors of Staphylococcus Aureus
12/08/2011	US20110300560 Novel members of the capsaicin/vanilloid receptor family of proteins and uses thereof
12/08/2011	US20110300559 Compositions and methods for diagnosing and treating cancer and neurodegenerative diseases related to beclin-1
12/08/2011	US20110300558 Nanoparticle for bioaffinity assays
12/08/2011	US20110300557 METHODS FOR PREDICTING PREGNANCY OUTCOME IN A SUBJECT BY hCG ASSAY
12/08/2011	US20110300556 Monoclonal antibodies detection methods for enzymes that confer resistance to 2,4-dichlorophenoxyacetic acid in plants
12/08/2011	US20110300555 Assay device comprising bubble-forming means
12/08/2011	US20110300554 Exponential isothermal self-sustained replication of an rna enzyme
12/08/2011	US20110300552 Systems and Methods for Determining Drug Resistance in Microorganisms
12/08/2011	US20110300551 Method of predicting clinical outcomes for melanoma patients using circulating melanoma cells in blood
12/08/2011	US20110300548 Gdf15 as molecular tool to monitor and enhance phenotypic stability of articular chondrocytes
12/08/2011	US20110300543 Methods for making induced pluripotent stem cells from mesenchymal stem cells
12/08/2011	US20110300533 Yeast Screens for Treatment of Human Disease
12/08/2011	US20110300531 Method and device to detect the presence of analytes in a sample
12/08/2011	US20110300529 Detection of ifi16 in body fluids
12/08/2011	US20110300232 EFFECTS OF NITRIC OXIDE (NO) AND iNOS ON EXPRESSION AND SIGNAL TRANSDUCTION IN CANCER AND ITS USE IN DRUG DISCOVERY AND CANCER THERAPY DESIGN
12/08/2011	US20110300206 Vaccines against chlamydial infection
12/08/2011	US20110300161 Methods for the Treatment and the Prognostic Assessment of Malignant Pleural Mesothelioma
12/08/2011	US20110300160 Sulfation of wnt pathway proteins
12/08/2011	US20110300159 Sulfonated Sclerostin, antibodies, epitopes and methods for identification and use therefor
12/08/2011	US20110300156 Human antibodies against tissue factor
12/08/2011	US20110300144 Methods and compositions for diagnosis and treatment of cancer
12/08/2011	US20110300140 Antigen binding polypeptides
12/08/2011	US20110300139 Generation, expression and characterization of the humanized k33n monoclonal antibody
12/08/2011	US20110300138 Human anti tshr antibodies
12/08/2011	US20110300131 Detection and treatment of pancreatic, ovarian and other cancers
12/08/2011	US20110300128 Use of foxp2 as a marker for abnormal lymphocytes and as a target for therapy of disorders associated with abnormal lymphocytes
12/08/2011	US20110300119 Methods of enriching and using regulatory t cells
12/08/2011	US20110300099 Multi-level specific targeting of cancer cells
12/08/2011	US20110300077 Human Anti-Alpha-Synuclein Antibodies
12/08/2011	US20110300076 METHODS FOR PREPARATION OF ZnTe NANOCRYSTALS
12/08/2011	US20110300074 3,6-disubstituted xanthylium salts
12/08/2011	US20110300069 Methods of Using Labeled Ligands Having Human CD4 Specificity
12/08/2011	US20110300068 Agent for prophylaxis or treatment of cancer
12/08/2011	US20110300022 Temperature-adjustable biochip assembly
12/08/2011	US20110297557 Underfill Management System for a Biosensor
12/08/2011	US20110297554 Complex Index Functions
12/08/2011	US20110297543 Autosomal-Dominant Polycystic Kidney Disease (ADPKD)
12/08/2011	US20110297540 Low Total Salt Reagent Compositions and Systems for Biosensors
12/08/2011	US20110297539 Water quality analyzer
12/08/2011	US20110297456 Scales Displaying Nutritional Information
12/08/2011	US20110297154 Control of supplied pressure in assisted ventilation
12/08/2011	US20110296933 Method and apparatus for characterizing the flowability of toner particles
12/08/2011	US20110296902 Method for metered dispensing of lubricant
12/08/2011	DE112006000374B4 Verfahren zum Bilden eines biologischen Sensors A method of forming a biological sensor
12/08/2011	DE102010022929A1 Verfahren zum Herstellen einer Bilipidschicht sowie Mikrostruktur und Messanordnung A method of manufacturing a microstructure and Bilipidschicht and measuring arrangement
12/08/2011	DE102010022836A1 Flüssigkeitstransport- und analytische Testvorrichtung Liquid transport and analytical test device
12/08/2011	DE102010022745A1 Device for calibrating breath alcohol testing devices, has dry gas adapter that is engaged with borehole, outer-sided chamfered edge and inner-sided chamfered edge in mouth-piece net lace
12/08/2011	DE102007027654B4 Verfahren zum Nachweis von Nukleinsäuren A method for detecting nucleic acids
12/08/2011	DE102005057191B4 Gewebeprozessor Tissue processor
12/08/2011	CA2837679A1 Composition for inducing proliferation or accumulation of regulatory t cells
12/08/2011	CA2836725A1 Materials and methods for diagnosing and predicting the course of prostate cancer
12/08/2011	CA2816532A1 Predicting plaque composition and phenotype in coronary arteries via hdl-subclass analysis, and methods related thereto
12/08/2011	CA2802607A1 Methods of diagnosing asthma
12/08/2011	CA2801770A1 Methods of treatment
12/08/2011	CA2801588A1 Gene expression signature as a predictor of chemotherapeutic response in breast cancer
12/08/2011	CA2801575A1 Methods for improving inflammatory bowel disease diagnosis
12/08/2011	CA2801509A1 Treatment drug for autoimmune diseases and allergic diseases
12/08/2011	CA2801379A1 A method of quantifying soil carbon
12/08/2011	CA2801299A1 Use of bacterial beta-lactamase for in vitro diagnostics and in vivo imaging, diagnostics and therapeutics
12/08/2011	CA2801190A1 Use of the sparc microenvironment signature in the treatment of cancer
12/08/2011	CA2801184A1 Peripheral blood sparc binding antibodies and uses thereof
12/08/2011	CA2801167A1 Xyxin fragment biomarker for diagnosis of colon cancer
12/08/2011	CA2801162A1 Diagnostic, screening and therapeutic applications of ocab-based tools
12/08/2011	CA2800921A1 Water-distribution system comprising a device for measuring the value of at least one parameter representing the water quality
12/08/2011	CA2800879A1 System and method for determining the asphaltene content of crude oil
12/08/2011	CA2800863A1 Method for producing tumor cell
12/08/2011	CA2800481A1 Method for decision support in allergy diagnosis
12/08/2011	CA2800281A1 Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of lysyl-trna synthetases
12/08/2011	CA2800023A1 Means and methods for diagnosing pancreatic cancer in a subject
12/08/2011	CA2799536A1 Markers for renal disease
12/08/2011	CA2799439A1 Monoclonal antibodies detection methods for enzymes that confer resistance to 2,4-dichlorophenoxyacetic acid in plants
12/08/2011	CA2799229A1 Method of toxicological evaluation, method of toxicological screening and associated system
12/08/2011	CA2798144A1 Method of detecting rupture of membranes
12/08/2011	CA2795972A1 Immuno-pet imaging of antibodies and immunoconjugates and uses therefor
12/07/2011	EP2392927A1 Diagnosis of metabolic disorders in HIV infected patients
12/07/2011	EP2392926A1 Urinary biomarkers in HIV infected subjects
12/07/2011	EP2392925A1 Methods and marker combinations for screening for predisposition to lung cancer
12/07/2011	EP2392924A1 Rapid ELISA
12/07/2011	EP2392923A1 Method of prodcucing proteins comprising unnatural amino acid
12/07/2011	EP2392922A1 Autonomous multi-parametric buoy for water sampling, monitoring, data collection, transmission, and analysis
12/07/2011	EP2392912A1 Reduction of carbon monoxide interference in gaseous analyte detectors
12/07/2011	EP2392907A1 System for identifying an analyte in a water sample
12/07/2011	EP2392768A1 Method and device for increasing the yield from a mineral deposit
12/07/2011	EP2392678A2 Prognosis prediction for colorectal cancer
12/07/2011	EP2392674A2 Cellular biomarker antioxidant assay and uses thereof
12/07/2011	EP2392667A2 Assay for phosphodiesterases
12/07/2011	EP2392659A2 Single domain TDF-related compounds and analogs thereof
12/07/2011	EP2392644A2 In vitro test system for viral infections

1 ... 678 679 680 681 682 683 684 685 686 687 688 689 690 691 692 693 694 695 696 697 698 ... 3937